3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
58
Phase 1
25
Phase 3
22
Phase 1/2
12
Phase EARLY_PHASE1
2
Phase 4
2
Phase 2/3
2
Status
Completed
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Liver Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Non-Small Cell Lung Cancer Metastatic
1
Neoplasms
1
Lung Neoplasms
1
Interventions
Pemetrexed
10
Cisplatin
9
Erlotinib Hydrochloride
8
Carboplatin
7
icotinib
5
Gefitinib
5
Docetaxel
5
endostar protein
3
Zoledronic Acid
3
Radiotherapy
3
Paclitaxel
3
Gemcitabine
3
Endostatins
3
Afatinib
3
tislelizumab
2
pembrolizumab
2
osimertinib
2
lorlatinib
2
flurbiprofen axetil
2
dexamethasone 21-phosphate
2
atezolizumab
2
Vinorelbine
2
Surgical Procedures, Operative
2
Saline Solution
2
Nivolumab
2
Drug Therapy
2
Dexamethasone
2
Chemoradiotherapy
2
trametinib
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Carcinoma, Non-Small-Cell Lung
×
atezolizumab
×
Clear all
NCT03285763
2025-01-23
TAIL
Hoffmann-La Roche
Phase 4
Completed
619 enrolled
22 charts
NCT04059887
2023-02-08
BUDDY
Chonnam National University Hospital
Phase 4
Completed
100 enrolled